Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Intangibles: 2021-2022

  • Whitehawk Therapeutics' Intangibles was N/A to $3.7 million in Q1 2022 from the same period last year, while for Mar 2022 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2021, which is N/A change from last year.
  • According to the latest figures from Q1 2022, Whitehawk Therapeutics' Intangibles is $3.7 million, which was down 1.78% from $3.8 million recorded in Q4 2021.
  • Whitehawk Therapeutics' Intangibles' 5-year high stood at $3.9 million during Q3 2021, with a 5-year trough of $3.7 million in Q1 2022.
  • Over the past 2 years, Whitehawk Therapeutics' median Intangibles value was $3.8 million (recorded in 2021), while the average stood at $3.8 million.